Similar articles

• [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].

  Sinagra G, Boccanelli A, Camerini F, Gavazzi A, Gronda E, Maggioni AP, Opasich C, Rapezzi C, Scherillo M, Tavazzi L. Sinagra G, et al. G Ital Cardiol. 1998 Jan;28(1):61-70. G Ital Cardiol. 1998. PMID: 9493048 Review. Italian. No abstract available.
• [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].

  vom Dahl J, Schotten U, Sasse A. vom Dahl J, et al. Dtsch Med Wochenschr. 1999 Sep 24;124 Suppl 2:S48-53. Dtsch Med Wochenschr. 1999. PMID: 10535047 Review. German. No abstract available.
• [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].

  Torp-Pedersen CT; Carvedilol Or Metoprolol European Trial. Torp-Pedersen CT, et al. Ugeskr Laeger. 2004 Aug 2;166(32):2671-4. Ugeskr Laeger. 2004. PMID: 15347171 Clinical Trial. Danish. No abstract available.
• Selective beta-blockers and mortality from heart failure.

  Seth S, Naik N, Mohan A. Seth S, et al. Natl Med J India. 1999 Sep-Oct;12(5):225-6. Natl Med J India. 1999. PMID: 10613003 No abstract available.
• [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].

  Swedberg K. Swedberg K. Lakartidningen. 2003 Sep 11;100(37):2852-4. Lakartidningen. 2003. PMID: 14558169 Swedish. No abstract available.